Ozempic Hype Forces Employer Calls on Obesity Coverage
Employers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
Read Morescrane92
South Carolina’s Bold Maternal Health Experiment Disappoints
A large randomized trial showed home visits from nurses for pregnant people did not improve their or their babies’ health outcomes.
Read More
How Patents Help Keep Obesity Drug Prices Sky-High
A recent JAMA study sheds light on how the manufacturers of a class of popular weight-loss drugs have avoided competition from more affordable generics.
Read More
How Smartwatches Could Lead Doctors to Overtreat Patients
A new study suggests doctors struggle to know when and how to act on heart rhythm data generated by patients’ smartwatches.
Read More
Experts Share Four Key Studies you Might have Missed this Summer
Experts from the Tradeoffs Advisory Board share some of their favorite new health policy studies.
Read More
Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Read More
Why an Influential Task Force Doesn’t Recommend Screening for Suicide Risk
New guidelines for clinicians suggest there’s not enough evidence to screen most adults for suicide risk.
Read More
Putting a Price Tag on Patients’ Social Needs
A study in JAMA Internal Medicine calculates the cost of fully meeting the social needs of primary care patients – and finds the current system falls short.
Read More
Can Immigration Help Solve the Nursing Home Staffing Crisis?
A recent NBER working paper looks at the effects of immigration into the U.S. on the staffing and quality of nursing homes.
Read More